
The growing presence of out-of-town universities in Washington underscores what has been true throughout D.C. history: The nation’s capital is very much a college town.

The growing presence of out-of-town universities in Washington underscores what has been true throughout D.C. history: The nation’s capital is very much a college town.

The top company received more than $280 million VC funding in 2018.

Seven firms brought in over $30 million last year, and five raised more than $70 million in venture capital.

In the last decade, crowdfunding has become a popular way to finance all sorts of projects and products. Biotech is no exception, but many question whether the high risk and long term nature of investing in the biotech industry makes it a good fit for equity crowdfunding.

The premier investor network in the Mid-Atlantic has entered into a resource partnership. Keiretsu Forum Mid-Atlantic and the CONNECTpreneur community have entered into an agreement that will advance innovation, entrepreneurship, and investment in the region.

By 2050, there will be two billion people that are 60 years or older globally. Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060.

Maryland Tech Council (MTC) announced today that the Montgomery County Economic Development Corporation (MCEDC) will continue its partnership with and support of MTC’s Venture Mentoring Services (VMS) program. MCEDC has funded the mentoring program for three years and will continue to support it in 2019-to further augment the growth of Montgomery County’s target industries-technology and life sciences, while providing a key component to sustain economic growth in the County.

Catalyze announces collaboration with Biopôle, providing dedicated services to members towards better access to non-dilutive funding opportunities.

In a move to reflect the reach into more states it has gained in recent years, MdBio Foundation unveiled a rebrand as Learning Undefeated on Tuesday.

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in pediatrics and neurology, announced today that it has moved its U.S. Corporate Offices to 540 Gaither Road Suite 400 located in Rockville, Maryland. The company had previously been based in Baltimore, Maryland.